Valneva SE Price to Sales Ratio 2021-2024 | VALN

Historical PS ratio values for Valneva SE (VALN) over the last 10 years. The current P/S ratio for Valneva SE as of September 19, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Valneva SE P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-09-19 6.02 4.12
2024-03-31 7.92 $1.46 5.41
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.419B $0.166B
Valneva SE is a specialty vaccine company. It is focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Valneva SE is based in Saint-Herblain, France.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $198.609B 25.65
Stryker (SYK) United States $139.112B 32.51
Boston Scientific (BSX) United States $123.274B 37.54
Medtronic (MDT) Ireland $114.744B 17.07
EssilorLuxottica (ESLOY) France $106.116B 0.00
Haleon (HLN) United Kingdom $47.707B 34.87
Lonza Group Ag (LZAGY) Switzerland $46.203B 0.00
ResMed (RMD) United States $35.702B 31.43
Koninklijke Philips (PHG) Netherlands $29.054B 22.08
Terumo (TRUMY) Japan $28.562B 40.34
Zimmer Biomet Holdings (ZBH) United States $21.656B 13.63
Baxter (BAX) United States $19.774B 13.41
Insulet (PODD) United States $16.665B 70.11
Smith & Nephew SNATS (SNN) United Kingdom $13.531B 0.00
Bio-Rad Laboratories (BIO) United States $9.604B 31.82
Demant (WILYY) Denmark $9.197B 0.00
BellRing Brands (BRBR) United States $7.682B 32.48
Lantheus Holdings (LNTH) United States $7.537B 18.09
ICU Medical (ICUI) United States $4.428B 42.25
TG Therapeutics (TGTX) United States $3.914B 41.44
Haemonetics (HAE) United States $3.842B 19.01
Neogen (NEOG) United States $3.799B 39.84
Perrigo (PRGO) Ireland $3.788B 11.97
GN Store Nord (GNNDY) Denmark $3.691B 22.23
Prestige Consumer Healthcare (PBH) United States $3.663B 18.25
Envista Holdings (NVST) United States $3.324B 17.73
QuidelOrtho (QDEL) United States $3.108B 19.59
Agios Pharmaceuticals (AGIO) United States $2.696B 0.00
Maravai LifeSciences Holdings (MRVI) United States $2.230B 0.00
Green Thumb Industries (GTBIF) United States $2.192B 36.79
LeMaitre Vascular (LMAT) United States $2.026B 54.00
AdaptHealth (AHCO) United States $1.520B 10.97
InMode (INMD) Israel $1.490B 9.49
Warby Parker (WRBY) United States $1.483B 0.00
AtriCure (ATRC) United States $1.403B 0.00
Owens & Minor (OMI) United States $1.237B 9.55
BioLife Solutions (BLFS) United States $1.187B 0.00
Verano Holdings (VRNOF) United States $1.110B 0.00
Evolus (EOLS) United States $1.037B 0.00
PetIQ (PETQ) United States $0.919B 23.30
Phibro Animal Health (PAHC) United States $0.908B 18.83
National Vision Holdings (EYE) United States $0.862B 27.40
Cresco Labs (CRLBF) United States $0.805B 0.00
Quanterix (QTRX) United States $0.594B 0.00
Surmodics (SRDX) United States $0.562B 119.39
ZimVie (ZIMV) United States $0.468B 43.49
VAREX IMAGING (VREX) United States $0.445B 13.43
Jin Medical (ZJYL) China $0.411B 0.00
Canopy Growth (CGC) Canada $0.401B 0.00
Cerus (CERS) United States $0.339B 0.00
TerrAscend (TSNDF) Canada $0.335B 0.00
Biote (BTMD) United States $0.331B 15.27
OraSure Technologies (OSUR) United States $0.324B 8.37
Aurora Cannabis (ACB) Canada $0.315B 0.00
Sanara MedTech (SMTI) United States $0.291B 0.00
Viemed Healthcare (VMD) United States $0.290B 31.08
Zynex (ZYXI) United States $0.264B 46.28
Utah Medical Products (UTMD) United States $0.236B 15.70
Omeros (OMER) United States $0.234B 0.00
Ayr Wellness (AYRWF) United States $0.221B 0.00
MacroGenics (MGNX) United States $0.213B 0.00
Organigram Holdings (OGI) Canada $0.192B 0.00
High Tide (HITI) Canada $0.172B 71.33
Capricor Therapeutics (CAPR) United States $0.162B 0.00
FitLife Brands (FTLF) United States $0.154B 20.74
Brainsway (BWAY) Israel $0.137B 163.80
TriSalus Life Sciences (TLSI) United States $0.135B 0.00
Rockwell Medical (RMTI) United States $0.129B 0.00
Quipt Home Medical (QIPT) United States $0.122B 0.00
Veru (VERU) United States $0.117B 0.00
Fonar (FONR) United States $0.110B 11.15
Oramed Pharmaceuticals (ORMP) United States $0.101B 24.70
Jushi Holdings (JUSHF) United States $0.100B 0.00
Zevia PBC (ZVIA) United States $0.087B 0.00
InterCure (INCR) Israel $0.085B 14.31
Cytosorbents (CTSO) United States $0.077B 0.00
Safety Shot (SHOT) United States $0.076B 0.00
Cellectar Biosciences (CLRB) United States $0.076B 0.00
Modular Medical (MODD) United States $0.074B 0.00
MariMed (MRMD) United States $0.065B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.055B 3.62
Exagen (XGN) United States $0.050B 0.00
Allurion Technologies (ALUR) United States $0.041B 0.00
Apyx Medical (APYX) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
Meihua Medical Technologies (MHUA) China $0.026B 0.00
Nephros (NEPH) United States $0.019B 0.00
Flora Growth (FLGC) United States $0.019B 0.00
GlucoTrack (GCTK) United States $0.016B 0.00
Innovative Eyewear (LUCY) United States $0.016B 0.00
GUARDION HEALTH (GHSI) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Agape ATP (ATPC) $0.007B 0.00
Sharps Technology (STSS) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
Senestech (SNES) United States $0.001B 0.00
Akanda (AKAN) United Kingdom $0.000B 0.00
United-Guardian (UG) United States $0.000B 20.48
SNDL (SNDL) Canada $0.000B 0.00